Covered recipient · General Payments record
PHUONG TINH NGUYEN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2023–2024
$557.84
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $427.72 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $94.81 | 4 |
| PFIZER INC. | $88.89 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $75.98 | 3 |
| ABBVIE INC. | $57.84 | 3 |
| Exact Sciences Corporation | $51.90 | 2 |
| Novo Nordisk AS | $34.23 | 1 |
| Solventum Corporation | $24.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.88 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105120863 | CMS |
| ABBVIE INC. | $14.86 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105120865 | CMS |
| ABBVIE INC. | $23.10 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105120867 | CMS |
| Exact Sciences Corporation | $18.08 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114562347 | CMS |
| Exact Sciences Corporation | $33.82 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114562351 | CMS |
| Lilly USA, LLC | $19.29 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135320073 | CMS |
| Lilly USA, LLC | $23.93 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135298691 | CMS |
| Lilly USA, LLC | $25.91 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135319705 | CMS |
| Lilly USA, LLC | $25.68 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135319709 | CMS |
| Novartis Pharmaceuticals Corporation | $30.48 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087128490 | CMS |
| Novartis Pharmaceuticals Corporation | $20.07 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087128512 | CMS |
| Novartis Pharmaceuticals Corporation | $25.43 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087128532 | CMS |
| Novo Nordisk Inc | $34.23 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096892369 | CMS |
| PFIZER INC. | $16.93 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131911987 | CMS |
| PFIZER INC. | $20.43 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131906702 | CMS |
| PFIZER INC. | $23.47 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131917567 | CMS |
| PFIZER INC. | $28.06 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131926220 | CMS |
| Solventum Corporation | $24.07 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144075524 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.